Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer, is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference.